Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease

Translational Research

Volumn 150, Issue 3, 2007, Pages 158-163

  Youssef, Maged Y Z ^a   Mojiminiyi, Olusegun A ^a   Abdella, Nabila A ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; LIPID;

ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DATA ANALYSIS; DIET RESTRICTION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANKIN SCALE; RATING SCALE; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 34548137030     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.02.006     Document Type: Article

References (33)

1. Bores G.M. Hyperhomocysteinaemia as a risk factor for arterial and venous disease. A review of evidence and relevance. Thromb Haemost 78 (1997) 520-522
2. Clarke R., Dalyl L., Robinson K., Naughten E., Calahare S., Fowler B., et al. Hyperhomocysteinaemia: an independent risk factor for vascular disease. N Engl J Med 324 (1991) 1149-1155
3. Moller J., Neilson G.M., Tvedegaarel K.C., Anderson N.T., and Jorgensen P.E. A meta analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest 60 (2000) 491-500
4. Verhoef P., Hennekens C.H., Allen R.H., Stapler S.P., Willet W.C., and Stamfer M.J. Plasma total homocysteine and risk of angina pectoris with subsequent coronary bypass surgery. Am J Cardiol 79 (1997) 799-801
5. Kuller L.H., and Evans K.W. Homocysteine, vitamins and cardiovascular disease. Circulation 98 (1998) 196-199
6. Morrow D.A., and Ridker P.M. C-reactive protein, inflammation and coronary risk. Med Clin North Am 84 (2000) 149-161
7. Di Napoli M., Papa F., and Bocola V. C-reactive protein in ishaemic stroke: an independent prognostic factor. Stroke 32 (2001) 917-924
8. Brott T., Adams Jr. H.P., Olinger C.P., Marler J.R., Barsan W.G., Biller J., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 70 (1989) 864-870
9. Wityke R.J., Pessin M.S., Kaplan R.F., and Caplan L.R. Serial assessment of acute stroke using the NIH Stroke Scale. Stroke 25 (1994) 362-365
10. Goldstein L.B., Bertels C., and Davis J.N. Interrater reliability of NIH stroke scale. Arch Neurol 46 (1989) 660-662
11. Andersson A., Lindgern A., and Hultberg B. Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clin Chem 41 (1995) 361-366
12. Refsum H., Fiskerstrand T., Guttormsen A.B., and Ueland P.M. Assessment of homocysteine status. J Inher Metab Dis 20 (1997) 286-294
13. Ridker P.M. Inflammation in atherosclerosis: how to use high sensitivity C- reactive protein (hsCRP) in clinical practice. Am Heart Hosp J 2 (2004) 4-9
14. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
15. Perry I.J., Refsum H., and Morris R.W. Prospective study of serum total homocysteine concentration and risk of stroke in middle aged British men. Lancet 346 (1995) 1395-1398
16. Yoo J., and Chung C.K.S. Relation of plasma homocysteine to cerebral infarction and cerebral atherosclerosis. Stroke 29 (1998) 2478-2483
17. Malinow M.R., Neito F.J., and Szklo M. Carotid artery intimal medial wall thickening and plasma homocysteine in asymptomatic adults: the atherosclerosis risk in a community study. Circulation 87 (1993) 1107-1113
18. Kang S.S., Wong P.W., and Malinow M.R. Hyperhomocysteinaemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 12 (1992) 279-298
19. Nishinaga M., Ozawa T., and Shimada K. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparin sulfate expression in cultured porcine aortic endothelial cells. J Clin Invest 92 (1993) 1381-1386
20. Loscalzo J. The oxidant stress of hyperhomocysteinaemia. J Clin Invest 98 (1996) 5-7
21. Rodgers G.M., and Conn M.T. Homocysteine an atherogenic stimulus reduces protein C activation by arterial and venous endothelial cells. Blood 75 (1990) 895-901
22. Di Napoli M., and Papa F. Inflammation, hemostatic markers and antithrombotic agents in relation to long term risk of new cardiovascular events in first ever ischaemic stroke patients. Stroke 33 (2002) 1763-1771
23. Lindgren A., Brattstrom L., Norving B., Hultberg B., Anderson A., and Johansson B.B. Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 26 (1995) 795-800
24. Meiklejohn D.J., Vickers M.A., Dijkhuisen R., and Greaves M. Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. Stroke 32 (2001) 57-62
25. Howard V.J., Sides E.G., Newman G.C., Cohen S.N., Howard G., Malinow M.R., et al. Stability of plasma homocysteine in the acute phase after stroke. Stroke 33 (2002) 473-478
26. Mizrahi E.H., Fleissig Y., Arad M., and Adunsky A. Plasma homocysteine level and functional outcome of patients with ischaemic stroke. Arch Phys Med Rehab 86 (2005) 60-63
27. Winbeck K., Poppert H., Etgen T., Conrad B., and Sander D. Prognostic relevance of early serial C-reactive protein measurements after first ischaemic stroke. Stroke 33 (2002) 2459-2475
28. Muir K.W., Weir C.J., Alwan W., Squire I.B., and Lees K.R. C-reactive protein and outcome after ischaemic stroke. Stroke 30 (1999) 981-985
29. Bucher H.C., Griffith L.E., and Guyatt G.H. Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized controlled trials. Ann Int Med 128 (1998) 89-95
30. Ridker P.M., Rifai N., and Pfeffer M.A. Inflammation pravastatin and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 98 (1998) 839-844
31. Cernak J., Key N.S., Bach R.R., Balla J., Jacob H.S., and Vercelotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82 (1993) 513-520
32. Iso H., Moriyama Y., Sato S., Kitamura A., Tanigawa T., Yamagishi K., et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation 109 (2004) 2766-2772
33. Engström G., Lind P., Hedblad B., Stavenow L., Janzon L., and Lindgärde F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation 105 (2002) 2632-2637